European Medicines Agency (EMA) Patients' and Consumers' (PCWP) and Healthcare Professionals' (HCPWP) Working Parties meeting with all eligible organisations

• Date:
  Otrdiena, 14 Novembris 2023, Visu dienu
  Trešdiena, 15 Novembris 2023, Visu dienu
• Vieta:
  European Medicines Agency, Amsterdam, the Netherlands

Event summary

This meeting brings together all eligible patient and consumer and healthcare professionals organisations and members of the Patients' and Consumers' Working Party (PCWP) and Healthcare Professionals' Working Party (HCPWP).

The meeting focuses on the following topics:

• Availability and accessibility of medicines
• EMA data related initiatives and digitalisation
• Regulatory science and innovation
• Communications

 Other topics for discussion include the scientific committees' feedback and Members' voice.

Documents

Agenda - PCWP/HCPWP and all eligible organisations meeting (Nov 2023)

Adopted Reference Number: EMA/236061/2023

Meeting summary - PCWP/HCPWP and all eligible organisations meeting (Nov 2023)

Reference Number: EMA/510807/2023

Presentation - Strengthening the regulatory/HTA interface: Update on the support to the HTA Regulation implementation - M. Berntgen, F. Cerreta (EMA)

Presentation - HTA Stakeholder Network - B. Dajka, V. Barbuto (EC)

Presentation - Update on preparedness activities - E. Matelyte (EMA)

Presentation - Union list of Critical Medicines - J. Ferreira, I. Abed (EMA)

Presentation - ECHA proposal to ban PFAS – potential impact on availability of medicines - M. Alcaraz (EMA)

Presentation - Update on EU repurposing pilot - C. Bouygues (EMA)

Presentation - EMA Workshop on generating clinical evidence for treatment and prevention options for Long-COVID/Post-acute sequelae condition (PASC) - S. Buchholz (EMA)

Presentation - Skills Training for Young Patient Advocates (STYPA) 2023 - C. Louati (EPF)

Presentation - Next-generation health guidelines - I. Agache (EAACI)

Presentation - Highlights 2023 - I. Silva, M. Mavris (EMA)

Presentation - COMP Feedback - M. Cavaller, E. Rook, T. Leest

Presentation - Patient Experience Data pilot project – M. Cavaller

Presentation - Highlights on the Committee for Advanced Therapies - M. de Lemus

Presentation - CHMP feedback - C. Prieto, F. Ventura

Presentation - PDCO update - J. Taminiau

Presentation - Update on Patient Experience Data - R. Gonzalez-Quevedo (EMA)

Presentation - Big Data Steering Group Workplan - D. Umuhire (EMA)

Presentation - DARWIN EU - A. Segec (EMA)

Presentation - Delivering on stakeholders’ requirements for AI - L. Pinheiro (EMA)

Presentation - Facilitating innovation in regulatory science: research needs and multi-stakeholder collaboration - R. Herold (EMA)

Presentation - Improving understanding of biosimilars: Toolkit for Member States - B. Duggan (HMA), R. Gonzalez-Quevedo (EMA)

Presentation - EMA's corporate website and accessibility - C. Gadd (EMA)

Presentation - Collaboration with eligible organisations in the implementation of the social media strategy - L. Herold, G. Gabrielli, C. Enachioiu (EMA)

Presentation - Goal Attainment Scaling - F. Houÿez (EURORDIS)

Presentation - Antimicrobial stewardship and public awareness - M. Rodzinka-Verhelle (CPME)